Condition
Leukocyte Adhesion Deficiency Syndrome
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed2
Unknown1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00023010CompletedPrimary
Gene Therapy for Patients With Leukocyte Adherence Deficiency (Follow-Up of Phase 1 Trial)
NCT00006054Not ApplicableTerminated
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
NCT00001905Phase 2CompletedPrimary
Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I
NCT00004341Unknown
Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders
Showing all 4 trials